An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC
Clinical trial NCT07760844 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07760844
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-09-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.